Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Stockholder Note Receivable
Retained Earnings/(Deficit)
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020   145,196,000        
Beginning balance at Dec. 31, 2020 $ 1,481,413 $ 1,452 $ 1,569,905 $ (15,000) $ (71,714) $ (3,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (579,369)       (579,369)  
Other comprehensive income (loss) 214         214
Share-based compensation 334,339   334,339      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 3,843   3,843      
Issuance of common stock in connection with the IPO and over-allotment exercise, net of offering costs (in shares)   40,582,000        
Issuance of common stock in connection with the IPO and over-allotment exercise, net of offering costs 701,367 $ 406 700,961      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   6,687,000        
Issuance of common shares in connection with the vesting of restricted stock units 149,585 $ 67 149,518      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   595,000        
Issuance of common shares in connection with the vesting of restricted stock units 0 $ 6 (6)      
Cancellation of stockholder note receivable 0   (15,000) 15,000    
Issuances of common stock in connection with business acquisitions 0          
Ending balance (in shares) at Dec. 31, 2021   193,060,000        
Ending balance at Dec. 31, 2021 2,091,392 $ 1,931 2,743,560 0 (651,083) (3,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (1,793)       (1,793)  
Other comprehensive income (loss) (6,206)         (6,206)
Share-based compensation 37,291   37,291      
Stock option exercises (in shares)   363,000        
Stock option exercises 3,755 $ 4 3,751      
Equity issuance costs (270)   (270)      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   848,000        
Issuance of common shares in connection with the vesting of restricted stock units (554) $ 8 (562)      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   0        
Issuance of common shares in connection with the vesting of restricted stock units 646 $ 0 646      
Issuances of common stock in connection with business acquisitions $ 0          
Ending balance (in shares) at Dec. 31, 2022 194,271,000 194,271,000        
Ending balance at Dec. 31, 2022 $ 2,124,261 $ 1,943 2,784,416 0 (652,876) (9,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 76,063       76,063  
Other comprehensive income (loss) 2,297         2,297
Share-based compensation $ 31,151   31,151      
Stock option exercises (in shares) 1,441,000 1,441,000        
Stock option exercises $ 15,770 $ 14 15,756      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   597,000        
Issuance of common shares in connection with the vesting of restricted stock units (381) $ 6 (387)      
Issuance of common stock in connection with the employee stock purchase plan (in shares)   272,000        
Issuances of common stock in connection with the employee stock purchase plan 3,479 $ 3 3,476      
Issuances of common stock in connection with business acquisitions (in shares)   90,000        
Issuances of common stock in connection with business acquisitions $ 1,472 $ 1 1,471      
Ending balance (in shares) at Dec. 31, 2023 196,671,000 196,671,000        
Ending balance at Dec. 31, 2023 $ 2,254,112 $ 1,967 $ 2,835,883 $ 0 $ (576,813) $ (6,925)